Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2010
12/08/2010CN101904970A Traditional Chinese medicine preparation for treating nephritis
12/08/2010CN101904938A Kidney-tonifying heath traditional Chinese medicine composition and preparation method thereof
12/08/2010CN101904867A Adsorbent for an oral administration, and agent for treatingor preventing renal or liver disease
12/08/2010CN101904859A Rhoifolin and hyperin composition and application of medicines prepared therefrom
12/08/2010CN101904856A Application of 1,6-diphosphofructose and derivative thereof in preparing animal medical health care products
12/08/2010CN101904817A Cefsulodin sodium liposome injection
12/08/2010CN101904812A Compositions and methods for transdermal oxybutynin therapy
12/08/2010CN101569718B Chinese medicament for clearing heat, releasing toxin, removing swelling and dissipating stagnation
12/08/2010CN101375989B Anti-inflammation formulation for treating hyperplastic prostate gland and preparation method thereof
12/08/2010CN101358173B Aspergillus niger ZJUT712 and application thereof in arctium fruit preparation by solid-state fermentation
12/08/2010CN101347557B Medicament composition for refreshment and intelligence development and preparation and use thereof
12/08/2010CN101347465B Xylaria nigripes fermentation liquor powder and preparation and use
12/08/2010CN101234146B Traditional Chinese medicine preparation for treating urinary system affection and preparation thereof
12/08/2010CN101229238B Chinese traditional medicine preparation for treating prostate disease
12/08/2010CN101072752B Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same
12/07/2010US7847079 Albumin fusion proteins
12/07/2010US7847068 Neutralizing human anti-IGFR antibody
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010US7846924 Cyanopyrroles
12/07/2010US7846425 high shear nonaqueous granulation; treating renal disease; sevelamer is polyallylamine-epichlorohydrin copolymer and binds phosphate; tablet form
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2436409C Kappa opioid receptor ligands
12/07/2010CA2434203C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
12/07/2010CA2299632C Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138621A2 Diagnosing and treating iga nephropathy
12/02/2010WO2010138382A1 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
12/02/2010WO2010137716A1 Orally disintegrating tablet which contains precipitated calcium carbonate as active ingredient
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME
12/02/2010US20100305212 Therapeutic compounds
12/02/2010US20100305200 Compounds that modulate intracellular calcium
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305179 Oral sustained-release tablet
12/02/2010US20100305166 Novel compounds
12/02/2010US20100305162 Methods for the Synthesis of Pyridoxamine
12/02/2010US20100305159 Crystalline form of piperidine compound
12/02/2010US20100305158 Method for the treatment or prevention of lower urinary tract symptoms
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010US20100305109 Potassium channel modulators
12/02/2010US20100305105 Phenylsulfoxyoxazole compound inhibitors of urea transporters
12/02/2010US20100305085 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
12/02/2010US20100305066 Fused Thiophene Derivatives as Kinase Inhibitors
12/02/2010US20100305052 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
12/02/2010US20100305024 Methods of inhibiting calcineurin with apoe analogs
12/02/2010US20100303926 Organic compounds
12/02/2010US20100303914 Self-Gelling Alginate Systems and Uses Thereof
12/02/2010US20100303896 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
12/02/2010US20100303822 Polypeptides from non-typeable haemophilus influenzae
12/02/2010US20100303815 METHOD OF TREATING ANEMIA BY ADMINISTERING IL 1ra
12/02/2010US20100303807 Methods for the treatment of il-1beta related diseases
12/02/2010US20100303798 Methods of Treating Urogenital-Neurological Disorders Using Neurotrophin Retargeted Endopepidases
12/02/2010US20100303794 Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases
12/02/2010US20100303787 Methods of Treating Urogenital-Neurological Disorders Using Galanin Retargeted Endopepidases
12/02/2010US20100303783 Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases
12/02/2010US20100303756 Methods of Treating Urogenital-Neurological Disorders Using Interleukin Retargeted Endopepidases
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256114A1 Amide derivative and pharmaceutical composition containing the same
12/01/2010EP2255674A1 Soybean protein material for patients with renal disease and foods made from the same
12/01/2010EP2254870A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
12/01/2010EP2254869A2 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1943360B Mirobial source herbicide and its preparing method and use
12/01/2010CN101903362A Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists
12/01/2010CN101903359A Triazole-substituted arylamide derivatives and their use as P2X3 and /or P2X2/3 purinergic receptor antagonists
12/01/2010CN101899078A Extraction method of glossy privet fruit glycoside and application of glossy privet fruit glycoside in preparation of medicament
12/01/2010CN101899053A C crystal form solid matter of bergenin and preparation method and application thereof
12/01/2010CN101899052A B-crystal form solid matter of bergenin and preparation method and application thereof
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101899039A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
12/01/2010CN101897979A Targeted medicament for curing prostate diseases
12/01/2010CN101897970A Compositions and methods for treating diabetes
12/01/2010CN101897942A Method for detecting medicine composition for warming spleen and tonifying kidney and releasing turbidity and eliminating stasis
12/01/2010CN101897912A Bamboo shoot sterol soft capsules and application thereof
12/01/2010CN101897911A Preparation for treating gonorrhea
12/01/2010CN101897900A Chinese medicinal formula for treating lithangiuria
12/01/2010CN101897887A Nourishing stomach-clearing agent
12/01/2010CN101897880A Liquor for detoxifying and maintaining kidney
12/01/2010CN101897831A Method for extracting and separating medlar total alkaloids from medlar
12/01/2010CN101897795A Chinese medicinal pills for treating nephritis
12/01/2010CN101897786A Application of total flavonoids of murraya paniculata leaves in preparing drugs for preventing and treating diabetic nephropathy
12/01/2010CN101897734A Method for preparing fortune's drynaria rhizome active ingredient
12/01/2010CN101897733A Drug for curing bladder stone and preparation method thereof
12/01/2010CN101897724A Method for producing a soft tissue filler and method for producing an adipose tissue transplant
12/01/2010CN101897716A Application of astilbin in preparing drugs capable of curing or preventing acute renal failure
12/01/2010CN101897715A Nuezhenoside and rhoifolin composition and use thereof in preparation of drugs
12/01/2010CN101897713A Medicinal preparation
12/01/2010CN101897707A Tablet capsule loaded with dutasteride tablet and tamsulosin tablet
12/01/2010CN101897698A Sugar-lowering drug composition containing vildagliptin and B vitamins and application thereof
12/01/2010CN101897697A Sugar-lowering drug composition and application
12/01/2010CN101897696A Sugar-lowering drug composition and application thereof
12/01/2010CN101897695A Medicinal preparation for treating prostatitis
12/01/2010CN101897675A Solid oral medicinal composition containing valsartan or pharmaceutically acceptable salts of valsartan
12/01/2010CN101496877B Chinese-medicine mixture for treating prostatitis